Charles Elliott Sigal Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles Elliott Sigal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles Elliott Sigal. Charles Elliott Sigal is a Director in Adaptimmune Therapeutics PLC ($ADAP) and a Director in Surface Oncology, Inc. ($SURF) and a Director in Vir Biotechnology, Inc. ($VIR).
Address: 32 BREARLY ROAD PRINCETON 08540 NJ
Companies in which Charles Elliott Sigal is an Insider
Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Charles Elliott Sigal: Director
Holdings: 314,100 shares
Current Value: $1,422,873
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Surface Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Charles Elliott Sigal: Director
Holdings: 45,453 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vir Biotechnology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Charles Elliott Sigal: Director
Holdings: 3,374 shares
Latest Transaction: May 25 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Charles Elliott Sigal
Sentiment: All, ADAP, SURF, VIR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25 2021 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 45.28 | 6,748 | 305,549 | 6,748 | |
| May 25 2021 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 45.28 | 6,748 | 305,549 | 6,748 | |
| May 25 2021 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Grant | A | 0.00 | 3,374 | 0 | 3,374 | 0 to 3.4 K |
| May 25 2021 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Grant | A | 0.00 | 3,374 | 0 | 3,374 | 0 to 3.4 K |
| Jul 14 2020 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 48.71 | 57,777 | 2,814,318 | 57,777 | |
| Jul 14 2020 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 48.71 | 57,777 | 2,814,318 | 57,777 | |
| Jul 01 2020 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Option Exercise | A | 1.67 | 184,258 | 307,711 | 184,258 |